Verition Fund Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-14,228
Closed -$740K 358
2014
Q3
$740K Buy
14,228
+3,756
+36% +$195K 0.1% 133
2014
Q2
$486K Sell
10,472
-23,644
-69% -$1.1M 0.05% 233
2014
Q1
$1.36M Buy
+34,116
New +$1.36M 0.21% 68